| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.26 | 3e-13 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.24 | 5e-11 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.22 | 6e-10 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.25 | 3e-05 |